73 0

Full metadata record

DC FieldValueLanguage
dc.contributor.advisorSureshRamakrishna-
dc.contributor.author아룬판디안찬드라세카란-
dc.date.accessioned2024-03-01T07:33:10Z-
dc.date.available2024-03-01T07:33:10Z-
dc.date.issued2021.2-
dc.identifier.urihttp://hanyang.dcollection.net/common/orgView/200000485415en_US
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/188241-
dc.description.abstractDespiteadvancesincancertherapies,cancerisstillcausingmillionsofdeathsworldwide.Thestandardchemotherapeutictreatmentssuchaslowmolecularweightmoleculesfortreatingvariouscancershavenotbeensuccessful.Further,incrementinthedrugconcentrationisnotpossibleasthedosageisalreadyreachedthemaximumtolerablelevels.Raiseindosagelevelsmaycausedamagestovariousnormaltissuesororgans.Currentdevelopmentsincludetargeted,patient-specificorprecisiontherapiesarealternativeapproachesbuttheoutcomesareverybleak. Deubiquitinatingenzymes(DUBs)areafamilyofproteasesthatremoveubiquitinfromproteinsundergoingdegradation.DUBsplayseveralfunctionalrolesotherthandeubiquitinationsuchasconferringresistancetocancertherapiesandmediatestumorprogression.ConventionalscreeningmethodsforDUBshavelimitations.Aloss-of-functionstudybasedontheknockoutofDUBgenesinmammaliancellscanprovideanexcellentmodelforexploringDUBfunction.Here,IusedCRISPR-Cas9toperformgenome-scaleknockoutoftheentiresetofgenesencodingDUBsandthensystematicallyscreenedforDUBsthatinvolvedinthesmallmoleculeresistancemechanism. Toprovidetheproof-of-conceptthatoverexpressionofDUBsimpedessmallmolecule-basedtherapies,IexploitedourDUBknockoutlibrarytoscreenforprobableDUBcandidate(s)thatinvolveinresistancetoYM155,ananticancercompound.IhaveidentifiedUSP32asapotentialmolecularmarkerforYM155resistancebynegativelyregulatingSLC35F2,acarrierforYM155.IshowedthatUSP32andSLC35F2haveanegativecorrelationfromapanelofcancercelllinestested.CRISPR-mediatedgenerationofUSP32knockoutinMCF7andBT474cellspromotesYM155-drivenDNAdamagebyupregulatingSLC35F2.Importantly,USP32depletionenhancedYM155-mediatedsuppressionofcancerprogressioninvitroandinvivo. IalsoreportedthatourCRISPR-Cas9DUBknockoutlibraryapproachtoidentifyaregulatorforCdc25AtosensitizeATRinhibitors-basedcancertherapies.IfoundUSP3asdeubiquitinaseofCdc25A.DepletionofUSP3reducestheproteinlevelofCdc25AandsensitizesthecancercellstotheATRinhibitors,AZ20andcaffeine. Together,applyingmystrategytootherpotentialsmallmoleculesscheduledforcancertherapymayincreaseitsclinicalefficacy,especiallyduringpostclinicalstages.Ibelievethatthisapproachwillbehelpfultounderstandandovercometheresistanceproblemsexhibitedbyseveralsmallmoleculesandmayrewritetheirtherapeutics.-
dc.publisher한양대학교-
dc.titleCRISPR-baseddevelopmentandscreeningofdeubiquitinasesforthesensitizationofcancercellstosmallmoleculetherapies-
dc.typeTheses-
dc.contributor.googleauthorArunPandianChandrasekaran-
dc.contributor.alternativeauthor아룬판디안찬드라세카란-
dc.sector.campusS-
dc.sector.daehak의생명공학전문대학원-
dc.sector.department의생명과학과-
dc.description.degreeDoctor-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE